documents: FDA-2025-E-2426-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2025-E-2426-0002 | FDA | FDA-2025-E-2426 | Patent Extension Application from GlaxoSmithKline (on behalf of Glaxo Group Limited) | Other | Application | 2025-07-16T04:00:00Z | 2025 | 7 | 2025-07-16T04:00:00Z | 2025-07-16T22:17:18Z | 0 | 0 | 09000064b8e7b6d8 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref